go to DCU Home
Year 2015 - Present
SCT Presentation
 
  • Palesch YY, Ramakrishnan V, Foster L, Martin RL, Cassarly C, Barsan WG, Moy CS, Qureshi AI.
  • Outcome analysis for Antihypertensive Treatment for Acute Cerebral Hemorrhage (ATACH) II Trial using repeated systolic blood pressure measures. (Oral)
  • European Stroke Organization Conference, Prague, May 2017.
  • Farrant M, Johnston C, Easton D, Kim AS, Barsan W, Elm J, Lindblad A, Palesch Y.
  • Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke. (Poster)
  • European Stroke Organization Conference, Prague, May 2017.
  • Dillon, C., Zhao, W., Henry, A., Huang, D., & Kim, J.
  • Implementation of Clinical Trial Management Functionality for Remote Monitoring of Informed Consents
  • 38th Annual Society for Clinical Trial Meeting, May 2017, Liverpool, UK
  • Zhao, W., Pauls, K., Dillon, C., Kim, J.,Arnaud, C.,Ellerbe, C.,Elm, J.
  • Architectural Design of Automated Study Drug Distribution Coordination Module Integrated in Web-Based Clinical Trial Management System.
  • 38th Annual Society for Clinical Trial Meeting, May 2017, Liverpool, UK
  • Kurt Denninghoff, Tomas Nuño, Qi Pauls, Sharon D. Yeatts, Robert Silbergleit, Yuko Y. Palesch, Lisa H. Merck, Geoff Manley, and David W. Wright.
  • Prehospital Intubation is associated with favorable outcomes in ProTECT III.
  • SAEM
  • Dillon, C. & Zhao, W.
  • Enhancing Clinical Trial Quality and Efficiency by Integrating Trial Operation Information and Case Report Form Data.
  • 6th Annual Clinical Data Integration & Management meeting (2017, March). Princeton, NJ
  • Morotti A, Brouwers HB, Romero JM, Jessel MJ, Vashkevich A, Schwab K, Afzal MR, Cassarly C, Greenberg SM, Martin RH, Qureshi AI, Rosand J, Goldstein JN, On Behalf of ATACH-II and NETT Investigators*. (*Palesch Y acknowledged as a member of the ATACH II Investigators).
  • Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage. (Oral)
  • International Stroke Conference, Houston, February 2017.
  • Qureshi AI, Foster LD, Martin RL, Palesch YY, for ATACH II Investigators.
  • Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II Trial by As Treated Groups. (Oral)
  • International Stroke Conference, February 2017.
  • Qureshi AI, Foster LD, Martin RL, Palesch YY, for ATACH II Investigators.
  • Effect of Intensive Systolic Blood Pressure Lowering on Hematoma Expansion in Patients with Intracerebral Hemorrhage: Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II Trial. (Oral)
  • International Stroke Conference Nursing Symposium, February 2017.
  • Broderick JP, Palesch Y, Zhao W, Janis S, Moy C.
  • NIH StrokeNet Evolving Trial Proposal Process. (Poster)
  • International Stroke Conference, Houston, February 2017.
  • Peter Cotton, Qi Pauls, Valerie Durkalski, Jamila Keith, April Wood.
  • The EPISOD study; outcomes at 5 years.
  • DDW
  • Dillon, C. & Zhao, W.
  • Quality Data Management in Clinical Trials.
  • 4th Annual Innovations in Clinical Data Management meeting (2016, October). Arlington, VA.
  • Dillon, C., Huff, T., Meurer, W, & Zhao, W.
  • Challenges and Solutions for the Data Management of Emergency Clinical Trials.
  • The Society for Clinical Data Management, Annual meeting (2016, September). San Diego, CA.
  • Dillon, C., Elm, J., Harney, D., & Silbergleit, R.
  • Challenges and Solutions to the Coordination and Conduct of an Emergency Treatment Trial.
  • Presentation at the annual meeting of the Society for Clinical Trials (2016, May), Montreal, Canada.
  • Dillon, C., Link, M., & Silbergleit, R.
  • Central IRBs: Implementation, Effectiveness, and Optimization.
  • Presentation at the annual meeting of the Society for Clinical Trials (2016, May), Montreal, Canada.
  • Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW, for the ATACH II Investigators.
  • Antihypertensive Treatment for Cerebral Hemorrhage (ATACH) II Trial. (Oral)
  • Large Clinical Trials Plenary Session at the European Stroke Organization Conference, Barcelona, Spain, May 2016.
  • Palesch YY, Qureshi AI, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW, for the ATACH II Investigators.
  • Antihypertensive Treatment for Cerebral Hemorrhage (ATACH) II Trial: Subgroup analysis of data from Asian and non-Asian sites. (Oral)
  • Large Clinical Trials Plenary Session at the European Stroke Organization Conference, Barcelona, Spain, May 2016.
  • Peter Cotton, Valerie Durkalski, Qi Pauls, April Wood for the EPISOD study team.
  • The EPISOD study; outcomes at 3 years.
  • DDW
  • Liebeskind DS, Hill MD, Jovin TG, Menon BK, Nogueira RG, Zaidat OO, Scalzo F, Demchuk AM, Carrozzella J, von Kummer R, Khatri P, Goyal M, Yan B, Foster LD, Yeatts SD, Palesch YY, Broderick JP, Tomsick TA, Yoo AJ, for the IMS III Investigators.
  • Grade 2 or Partial Collaterals in IMS III: Half Full or Half Empty? (Poster)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Lansberg M, Bhat N, Broderick JP, Palesch YY, Lavori,PW, Lai TL, Yeatts SD, Albers GW.
  • A Novel Adaptive Trial Design Increases the Power of Endovascular Stroke Studies. (Poster)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Albers GA, Lansberg M, Kemp S, Christensen S, Tsai J, Mlynash M, Kim S, Zaharchuck G, Yeatts S, Wintermark M, Bammer R, Palesch Y, Lavori P, Broderick JP, Marks M, on behalf of the DEFUSE 3 Investigators.
  • DEFUSE 3 (Poster)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Broderick JP, Palesch YY, Zhao W, Moy CS, Janis S.
  • NIH StrokeNet Trial Proposal Process. (Poster)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Farrant M, Johnston C, Easton D, Kim AS, Barsan W, Elm J, Lindblad A, Palesch Y.
  • Platelet Oriented Inhibition in New TIA and Minor Ischemic Stroke. (Poster)
  • International Stroke Conference, Los Angeles, Feb 2016.
  • Simpson KN, Broderick JP, Simpson AN, Foster L, Hill MD, Jauch E, Palesch YY, for the IMS III Investigators.
  • Residual Stroke Morbidity and Post-acute Care Cost: the IMS III Economic Data Cohort. (Oral)
  • International Stroke Conference, Los Angeles, CA, February 2016.
  • Alejandro L. Suarez, MD, Peter B. Cotton, MD FRCP FRCS, Qi Pauls, MS, Valerie Durkalski-Mauldin, PhD, Gregory A. Coté, MD, MS.
  • Sphincter of Oddi dysfunction: A survey of current practice in USA.
  • DDW
  • Pauls K, Kim J, Zhao W.
  • Automated Coordination of Regulatory Document Collection in Large Clinical Trial Networks
  • Society for Clinical Trials 36th Annual Meeting, May 2015, Arlington, VA
  • Linke M, … Dillon C., et al.
  • Cooperative Review Process of the NIH StrokeNet Central Institutional Review Board
  • AAHRPP Annual Conference, May 2015, Chicago, IL
  • Dillon, C., Zhao, W., Simons, J., & Palesch, Y.
  • Building a Strong Data Management Center for the National Institutes of Health’s Stroke Trials Network.
  • Presentation at the annual meeting of the Society for Clinical Trials (2015, May), Crystal City, MD.
  • Kim J, Zhoa W, Yeatts SD
  • Implementation of Advanced Randomization Algorithm with Integrated Study Drug Tracking
  • Society for Clinical Trials 36th Annual Meeting, May 2015, Arlington, VA, Oral presentation
  • Foster LD, Durkalski V.
  • Stopping Early in a Non-Inferiority Trial when the Primary Efficacy Outcome is Also the Primary Safety Outcome.
  • . Society for Clinical Trials Annual Meeting. Arlington, VA, 2015 May 19. (oral presentation)
  • Belagaje S, Foster L, Kissela B, Broderick J.
  • The Role of Discharge Disposition in the Interventional Management of Stroke (IMSIII) Trial.
  • American Academy of Neuroradiology Annual Meeting, Washington, DC, 2015 Apr. (poster)
  • Tomsick T, Foster LD, Yeatts SD, Hill MD, Carrozzella J, Liebskind DS, Khatri P, Goyal M, Puetz V, Dzialowski I, Morales H, Demchuck AM, Palesch YY, Broderick JP.
  • Intraarterial (IA) Iodinated Radiographic Contrast Media (IRCM) Effect in the Interventional Management of Stroke (IMS) III Trial.
  • International Stroke Conference, Nashville, TN, 2015 Feb. (poster)
  • Vagal A, Foster L, Menon B, Livorine A, Shi J, Qazi E, Demchuck A, Yeatts S, Hill M, Tomsick T, Goyal M.
  • . Multimodal CT Imaging: Time to Treatment and Outcomes in the Interventional Management of Stroke (IMS) III Trial.
  • International Stroke Conference, Nashville, TN, 2015 Feb. (oral presentation)
go to DPHS

go to MUSC